The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors influencing BRAFV600 mutation testing quality in melanoma: Results from a large, non-interventional, multicenter study in Germany.
 
Arndt Hartmann
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; Roche/Genentech
Research Funding - BioNTech; BioNTech (Inst)
 
Peter Schirmacher
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
William Sterlacci
No Relationships to Disclose
 
Winfried Koch
Stock and Other Ownership Interests - Small amounts of shares in several Pharma companies
Honoraria - Payment as freelance statistician from many
Consulting or Advisory Role - Statistical consulting for many companies
 
Birgit Schif
Employment - Roche/Genentech
 
Claus Garbe
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche/Genentech
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche/Genentech
Research Funding - Bristol-Myers Squibb; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche/Genentech